ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1445

MRI Bone Erosions in RA Patients Relatives with Clinically Suspicious Arthralgia

David Vega-Morales1, Jorge Esquivel-Valerio2, Mario Alberto Garza-Elizondo3, Dionicio A. Galarza-Delgado4, Miguel A Villarreal-Alarcón5, Cassandra Skinner-Taylor1, Diana Flores-Alvarado6, Janett Riega-Torres7, Lorena Pérez-Barbosa8, Brenda Vazquez-Fuentes9 and Maria Del Carmen Larios-Forte1, 1Rheumatology, University Hospital “Dr. José Eleuterio González”, UANL, Monterrey, Mexico, 2Rheumatology, University Hospital “Dr. José Eleuterio González”, UANL, Mexico, Monterrey, Mexico, 3Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 4Chief of Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico, 5Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. Jose Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 6Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 7University Hospital “Dr. José Eleuterio González”, UANL, Monterrey, Mexico, 8Hospital Universitario, Monterrey, Mexico, 9Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: MRI, radiology and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) has a preclinical phase without symptoms that progress to symptomatic phases. Clinically suspect arthralgia (CSA) refers to patients with symptoms without clinically apparent synovitis. The presence of erosions of grade 2 or greater by MRI was reported to be specific to the diagnosis of RA. We do not know the frequency of RA specific erosions, defined by RAMRIS in CSA patients.

Methods:

Cross-sectional and observational study with 60 patients older than 18 years, divided into two groups: CSA group: n = 23 (38%) RA first-degree relatives with hand arthralgia without clinical inflammation, and RA group: n = 37 (%) patients who met 2010 ACR/EULAR criteria. MRI images were evaluated looking for synovitis, bone erosion, and bone marrow edema (BME). The bone erosions were scored on a scale of 0 to 10 based on the proportion of eroded.

Results:

Baseline and clinical characteristics are depicted in table 1. No difference was found in the frequency of patients without any bone erosion in MCP between CSA versus RA, 7/22(31.8%) and 12/38(31.6%), respectively. However, 18/60(30%) patients had ≥ 2 bone erosions, 6/22(27.3%) in CSA patients and 12/38(31.6%) in established RA patients (p=0.72).

Conclusion:

There were a similar number of patients with bone erosions Grade ≥2 in both groups. The presence of the combination of the MCP joints of bone erosions with bone edema and synovitis is more frequent in patients with RA compared to patients with CSA.

Table 1: Baseline characteristics of CSA patients and RA patients

TOTAL

(N=60)

Total

n = 60

(100%)

CSA

n = 22 (36.6%)

RA

n = 38

(63.3%)

Age in years. median

(IQR)

41.5(26)

35(12)

49.5(23)

> 40 years. n(%)

31(51.7)

5(22.7)

26(68.4)

≤40 years. n(%)

29(48.3)

17(77.3)

12(31.6)

Female. n(%)

50(83.3)

17(77.3)

33(86.8)

Dominant Hand: Right

55(91.7)

21(95.4)

34(89.5)

Symptoms duration in months. Median (IQR):

6(8)

65(33.5)

PVAS (0-100), median(IQR)

20(50)

0(0)

3.5(3)

66 SJC, median (IQR)

3(9)

0(2)

5(8)

68 TJC: median (IQR)

5(12)

0(5)

8(11)

ACPA positivity, n(%)

19/45(42.2)

8/21(38.0)

11/24(45.8)

RF positivity, n(%)

42/50(84)

20/21(95.2)

22/29(75.8)

CRP (mg/dl), median(IQR)

0(1)

0(1)

0.5(1)

CSA, clinically suspect arthralgia (CSA); RA, rheumatoid arthritis; ACPA, anti-citrullinated protein antibodies; CRP, C-reactive protein; RF, rheumatoid factor; ESR, erytrosedimentation rate; PVAS, Patient Global Assessment of the Disease Activity; SJC, swollen joints count; TJC, tender joint count.

Table 2: Frequencies of patients with RA and CSA with erosions and with erosions and with the simultaneous presence of local inflammation in MCP joints.

Total

of

Patients

N=60

Erosion+

BME-

Synovitis-

n=1

Erosion+

BME+

Synovitis-

n=3

Erosion+

BME-

Synovitis+

n=18

Erosion+

BME+

Synovitis+

n=19

Number of MCP bones without erosions, n=19

RA < 40 years

n= 12 pt

0

0

3(2.5%)

6(50%)

3(25%)

RA ≥ 40 years

n=26 pt

0

0

8(30.7%)

9(34.6%)

9(34.6%)

CSA < 40 years

n=17 pts

1(5.8%)

1(5.8%)

6(35.3%)

3(17.6%)

6(35.2%)

CSA ≥ 40 years

n=5 pts

0

2(40%)

1(20 %)

1(20%)

1(20%)

Inflammation was defined as the presence of synovitis and/or bone marrow oedema; The presence of BME and/or synovitis was defined as a score of ≥1; MCP, metacarpo–phalangical joint; RA, rheumatoid arthritis; CSA, clinically suspect arthralgia (CSA).


Disclosure: D. Vega-Morales, None; J. Esquivel-Valerio, None; M. A. Garza-Elizondo, None; D. A. Galarza-Delgado, None; M. A. Villarreal-Alarcón, None; C. Skinner-Taylor, None; D. Flores-Alvarado, None; J. Riega-Torres, None; L. Pérez-Barbosa, None; B. Vazquez-Fuentes, None; M. D. C. Larios-Forte, None.

To cite this abstract in AMA style:

Vega-Morales D, Esquivel-Valerio J, Garza-Elizondo MA, Galarza-Delgado DA, Villarreal-Alarcón MA, Skinner-Taylor C, Flores-Alvarado D, Riega-Torres J, Pérez-Barbosa L, Vazquez-Fuentes B, Larios-Forte MDC. MRI Bone Erosions in RA Patients Relatives with Clinically Suspicious Arthralgia [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/mri-bone-erosions-in-ra-patients-relatives-with-clinically-suspicious-arthralgia/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-bone-erosions-in-ra-patients-relatives-with-clinically-suspicious-arthralgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology